1. Claus, R.A., Bunck, A.C., Bockmeyer, C.L., Brunkhorst, F.M., Lösche, W., Kinscherf, R. & Deigner, H.P. (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J., 19, 1719-1721.
2. Doehner, W., Bunck, A.C., Rauchhaus, M., von Haehling, S., Brunkhorst, F.M., Cicoira, M., Tschope, C., Ponikowski, P., Claus, R.A. & Anker, S.D. (2007) Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur. Heart J., 28, 821-828.
3. Górska, M., Baranczuk, E. & Dobrzyn, A. (2003) Secretory Zn2+-dependent sphingomyelinase activity in the serum of patients with type 2 diabetes is elevated. Horm. Metab. Res., 35, 506-507.
4. Grammatikos, G., Mühle, C., Ferreiros, N., Schroeter, S., Bogdanou, D., Schwalm, S., Hintereder, G., Kornhuber, J., Zeuzem, S., Sarrazin, C. & Pfeilschifter, J. (2014) Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. Biochim. Biophys. Acta, 1841, 1012-1020.
5. Grassmé, H., Riehle, A., Wilker, B. & Gulbins, E. (2005) Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J. Biol. Chem., 280, 26256-26262.